DNA 与 RNA 合成研究回顾：2024 年

全球 DNA定序市场规模预计将从 2024 年的148 亿美元增至 2029 年底的 348 亿美元，预测期间的复合年增长率为 18.6%。

全球临床应用次世代定序市场规模预计将从 2023 年的 219 亿美元成长到 2028 年的 529 亿美元，预测期内的复合年增长率为 19.3%。

全球 RNA定序市场规模预计将从 2024 年的 年终的 103 亿美元，预测期间的复合年增长率为 19.1%。

DNA 和 RNA 合成是去氧核糖核酸（DNA）和核糖核酸（RNA）的人工生产。建构 DNA 和 RNA 的合成技术的发展提高了我们理解和设计生物学的能力。我们提供各种类型的合成 DNA，包括寡核苷酸、基因、DNA 和 RNA 片段，并可根据客户需求进行客製化。合成 DNA 和 RNA 被用于开发新药和疫苗、遗传疾病的基因疗法以及用于检测病原体和疾病的分子诊断工具（如 PCR 检测和基于核酸的感测器）。

DNA 和 RNA 合成技术在合成生物学、分子遗传学和生物工程等科学领域至关重要，可为各种研究、诊断和治疗应用产生客自订的DNA 和 RNA 序列。基因组学研究的快速扩展、治疗性 DNA 和 RNA 应用的进步以及对个人化医疗的日益增长的需求，正在推动 DNA 和 RNA 合成市场的显着增长。 CRISPR、基因治疗和合成生物学的创新正在推动对 DNA 和 RNA 合成的需求激增，使其成为开发标靶治疗和创新基因研究解决方案的重要工具。

本研究评论包括 BCC Research 于 2024 年发布的有关基因编辑疗法、DNA定序、次世代定序、RNA定序RNAi 技术病毒载体和质体DNA 的报告的亮点和摘录，并包括每个市场概况的摘要、市场影响因素和市场机会的分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测，以及各个细分市场和细分市场的细分市场趋势、市场规模趋势和预测，以及各个细分市场和细分市场的细分市场。

目录

第 1 章 简介

2. 基因编辑治疗市场（BIO259A）

• 研究范围
• 市场展望
• 市场摘要
• 基因编辑治疗市场概览
• 基因组编辑工具的类型
• Meganucleases
• 锌指核酸酶
• 转录活化因子样效应核酸酶
• CRISPR/CRISPR 相关蛋白
• 基因编辑疗法
• 市场动态
• 市场推进因素
• 市场挑战
• 基因编辑治疗的新技术与机会
• 基础编辑
• PrimeEdit
• Cas-Clover 和 Cas-FOKl
• CRISPR 干扰和 CRISPR 激活
• RNA编辑
• 人工智慧在基因组编辑的应用
• 基因编辑治疗市场分析
• 概述
• Casgevy
• 基因编辑治疗市场按地区划分
• 北美洲
• 欧洲
• 新兴市场
• 基因编辑治疗市场的 ESG 表现
• 基因编辑公司的 ESG 实践
• BCC的结语

3. 全球 DNA定序：研究、应用与临床市场（BIO045J）

• 研究范围
• 市场展望
• 市场摘要
• 市场概况
• DNA 的重要性
• 遗传变异与分析
• NGS
• TGS（长读定序）
• 研究与应用
• 研发应用
• 应用领域
• D2C
• 生物製药
• 农业
• 法医学
• 微生物组
• 合成生物学
• 市场动态
• 市场推进因素
• 市场限制
• 新兴技术
• 长读定序技术
• SMRT定序
• 奈米孔定序
• 空间基因组学和转录组学
• 单细胞 DNA定序
• 超低输入定序
• CRISPR-Cas9、基因组编辑和定序技术的整合
• DNA定序中的人工智慧和机器学习
• 市场区隔：按技术
• 概述
• NGS
• TGS
• 桑格定序
• 焦磷酸测序
• 市场区隔：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他地区
• DNA定序序产业的 ESG 表现
• 环境绩效
• 社会绩效
• 管治绩效
• DNA定序产业的ESG风险评估
• BCC的结语

第 4 章次世代定序：新兴临床应用与全球市场（BIO126E）

• 研究范围
• 市场展望
• 市场摘要
• 市场概况
• 液体和组织切片检查
• 临床NGS的成长要素
• 主要趋势
• 市场动态
• 市场推进因素
• 市场限制
• 次世代定序新技术
• 研究与开发计划和项目
• 1+ Million Genomes
• Access to Treatment and Testing (ACTT)
• Access to Comprehensive Genomic Profiling Coalition (ACGP)
• Africa Pathogen Genomics Initiative
• Blood Profiling Atlas
• Cancer-ID
• Cancer Moon Shots Program
• China Precision Medicine Initiative
• ClinGen
• CTC Trap Consortium
• diaRNAgnosis Project
• Early Cancer Detection Consortium
• EpiFemCare
• France Genomic Medicine Plan
• Friends of Cancer Research Project
• Genomic Medicine Sweden
• HCA-Organoid
• Human Cell Atlas
• Human Immunomics Initiative
• Immunomonitor Consortium
• Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
• Intervene
• Liquid Biopsies and Imaging for Improved Cancer Care
• Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
• Liver Cancer Early Screening Comprehensive Prevention and Control Project
• Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
• Million Veteran Program
• Medical Genome Initiative
• MedSeq
• 市场区隔：依疾病类别
• 概述
• 市场区隔：按地区
• 北美洲
• 欧洲
• 亚太地区
• 次世代定序产业的 ESG 表现
• 案例研究
• BCC 的看法

5. RNA定序：技术与全球市场（BIO147B）

• 研究范围
• 市场展望
• 市场摘要
• 市场概况
• 技术背景
• 转录组学技术
• 转录组学的 RNA定序
• RNA-Seq 实验工作流程
• RNA定序的监管现状
• 成长战略提案
• 市场动态
• 市场驱动因素
• 市场限制
• 市场机会
• RNA定序市场的新兴技术和发展
• 单细胞 RNA定序
• 其他新兴单细胞技术
• 市场区隔：RNA定序产品
• 装置
• 工具和试剂
• 软体和服务
• 市场区隔：按地区
• 概述
• 北美洲
• 欧洲
• 亚太地区
• 其他地区
• RNA定序市场的永续性：ESG 视角
• RNA定序产业的 ESG 实践
• 环境绩效
• 社会绩效
• 管治绩效
• BCC的结语

6. RNAi技术与全球市场（BIO127C）

• 研究范围
• 市场展望
• 市场摘要
• 市场概况
• RNA干扰概述
• RNA干扰：作用机制
• 启动阶段
• 效应阶段
• 小干扰RNA（siRNA）
• 微型RNA （miRNA）
• 小髮夹 RNA（shRNA）
• 市场动态
• 市场驱动因素
• 市场问题
• RNAi 技术的新兴技术与机会
• 治疗
• 诊断
• 用于非侵入性健康监测的循环 miRNA 诊断
• 农业
• 按技术分類的市场
• 治疗
• 诊断
• 试剂和工具
• 农业
• 区域市场
• 概述
• 北美洲
• 欧洲
• 新兴市场
• RNAi 技术产业的永续性：ESG 视角
• 环境倡议
• 社会贡献活动
• 管治倡议
• 案例研究
• BCC的结语

7. 病毒载体和质体DNA：技术与全球市场（BIO192B）

• 研究范围
• 市场展望
• 市场摘要
• 市场概况
• 细胞和基因治疗
• 市场动态
• 市场推进因素
• 市场挑战
• 新科技和机会
• 病毒载体生产中的人工智慧
• 狗骨DNA
• FRAGment Recycler：质体DNA 合成新技术
• 病毒载体和质体DNA 技术市场（按产品类型）
• 病毒载体和质体DNA 技术市场（按应用）
• 病毒载体和质体DNA 技术市场（按地区）
• 概述
• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 其他地区
• 病毒载体和质体DNA 技术市场的永续性：ESG 视角
• 环境因素
• 社会因素
• 管治因素
• 主要公司ESG表现
• 主要企业ESG表现
• 龙沙：ESG 绩效
• 赛默飞世尔：ESG 绩效
• 结论

第 8 章 附录

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a CAGR of 19.3% from 2023 through 2028.

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a CAGR of 19.1% during the forecast period of 2024 to 2029.

Research Review Scope

DNA and RNA synthesis artificially manufactures deoxyribose nucleic acid (DNA) and ribonucleic acid (RNA). Developing synthetic techniques to construct DNA and RNA has improved the ability to understand and engineer biology. Different types of synthesized DNA, such as oligonucleotides, genes, and DNA and RNA fragments, are available and can be utilized per the customer's needs. Synthetic DNA and RNA are used to develop new drugs and vaccines, gene therapies for genetic disorders, and the development of molecular diagnostic tools, including polymerase chain reaction (PCR) assays and nucleic-acid-based sensors, to detect pathogens and diseases.

DNA and RNA synthesis technology is vital in scientific fields such as synthetic biology, molecular genetics, and bioengineering, creating custom DNA and RNA sequences for various research, diagnostic, and therapeutic applications. The rapid expansion of genomics research, advancements in therapeutic DNA and RNA applications, and the growing need for personalized medicine are driving exceptional growth in the DNA & RNA synthesis market. The innovations in CRISPR, gene therapy, and synthetic biology show that the demand for DNA and RNA synthesis has risen sharply, positioning it as a pivotal tool in developing targeted treatments and innovative genetic research solutions.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of DNA and RNA synthesis technology provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO259A Gene Editing Therapeutics Market
• BIO045J Global DNA Sequencing: Research Applied and Clinical Markets
• BIO126E Next-generation Sequencing: Emerging Clinical Applications and Global Markets
• BIO147B RNA Sequencing: Technologies and Global Markets
• BIO127C RNAi Technologies and Global Markets
• BIO192B Viral Vector and Plasmid DNA: Technologies and Global Markets

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Gene Editing Therapeutics Market (BIO259A)

• Scope of Report of Gene Editing Therapeutics
• Market Outlook of Gene Editing Therapeutics
• Market Summary
• Market Overview of Gene Editing Therapeutics
• Genome-Editing Tool Types
• Meganucleases
• Zinc Finger Nucleases
• Transcription Activator-like Effector Nucleases
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
• Gene editing Therapeutics
• Market Dynamics of Gene Editing Therapeutics
• Market Driver
• Market Challenges
• Emerging Technologies and Opportunities of Gene Editing Therapeutics
• Base Editing
• Prime Editing
• Cas-Clover and Cas-FOKl
• CRISPR Interference and CRISPR Activation
• RNA Editing
• Artificial Intelligence in Genome Editing
• Market Analysis of Gene Editing Therapeutics
• Overview
• Casgevy
• Market of Gene Editing Therapeutics by Region
• North America
• Europe
• Emerging Markets
• ESG Performance in Gene Editing Therapeutics Market
• ESG Practices in the Gene Editing Companies
• Concluding Remarks from BCC Research

Chapter 3 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)

• Scope of Report of DNA Sequencing: Research, Applied and Clinical Markets
• Market Outlook of DNA Sequencing: Research, Applied and Clinical Markets
• Market Summary of DNA Sequencing: Research, Applied and Clinical Markets
• Market Overview of DNA Sequencing: Research, Applied and Clinical Markets
• Importance of DNA
• Genetic Variation and Analysis
• NGS (Second-generation Sequencing)
• TGS (Long-read Sequencing)
• Research and Applied Applications
• R&D Applications
• Applied Applications
• Direct to Consumer
• Biopharma
• Agriculture
• Forensics
• Microbiome
• Synthetic Biology
• Market Dynamics of DNA Sequencing: Research, Applied and Clinical Markets
• Market Driver
• Market Restraint
• Emerging Technologies of DNA Sequencing: Research, Applied and Clinical Markets
• Long-read Sequencing Technologies
• SMRT Sequencing
• Nanopore Sequencing
• Spatial Genomics and Transcriptomics
• Single-cell DNA Sequencing
• Ultra-low Input Sequencing
• CRISPR-Cas9 and Genome-editing Integration with Sequencing Technologies
• AI and Machine Learning in DNA Sequencing
• Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Technology
• Overview
• NGS
• TGS
• Sanger Sequencing
• Pyrosequencing
• Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Performance in DNA Sequencing Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings in the DNA Sequencing Industry
• Concluding Remarks from BCC Research

Chapter 4 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126E)

• Scope of Report of Next-generation Sequencing
• Market Outlook of Next-generation Sequencing
• Market Summary of Next-generation Sequencing
• Market Overview of Next-generation Sequencing
• Liquid and Tissue Biopsy
• Growth Drivers of Clinical NGS
• Key Trends
• Market Dynamics of Next-generation Sequencing
• Market Driver
• Market Restraint
• Emerging Technologies of Next-generation Sequencing
• R&D Initiatives and Programs
• 1+ Million Genomes
• Access to Treatment and Testing (ACTT)
• Access to Comprehensive Genomic Profiling Coalition (ACGP)
• Africa Pathogen Genomics Initiative
• Blood Profiling Atlas
• Cancer-ID
• Cancer Moon Shots Program
• China Precision Medicine Initiative
• ClinGen
• CTC Trap Consortium
• diaRNAgnosis Project
• Early Cancer Detection Consortium
• EpiFemCare
• France Genomic Medicine Plan
• Friends of Cancer Research Project
• Genomic Medicine Sweden
• HCA-Organoid
• Human Cell Atlas
• Human Immunomics Initiative
• Immunomonitor Consortium
• Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
• Intervene
• Liquid Biopsies and Imaging for Improved Cancer Care
• Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
• Liver Cancer Early Screening Comprehensive Prevention and Control Project
• Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
• Million Veteran Program
• Medical Genome Initiative
• MedSeq
• Market Breakdown of Next-generation Sequencing by Disease Category
• Overview
• Market Breakdown of Next-generation Sequencing by Region
• North America
• Europe
• Asia-Pacific
• ESG Performance in Next-generation Sequencing Industry
• Case Study
• BCC Research Viewpoint

Chapter 5 RNA Sequencing: Technologies and Global Markets (BIO147B)

• Scope of Report of RNA Sequencing
• Market Outlook of RNA Sequencing
• Market Summary of RNA Sequencing
• Market Overview of RNA Sequencing
• Technology Background
• Transcriptomics Technologies
• RNA Sequencing for Transcriptomics
• RNA-Seq Experimental Workflow
• Regulatory Landscape of RNA Sequencing
• Growth Strategy Recommendations
• Market Dynamics of RNA Sequencing
• Market Drivers
• Market Restraints
• Market Opportunity
• Emerging Technologies and Developments of RNA Sequencing Market
• Single-Cell RNA Sequencing
• Other Emerging Single-Cell Technologies
• Market Breakdown of RNA Sequencing by Product
• Instruments
• Tools and Reagents
• Software and Services
• Market Breakdown of RNA Sequencing by Region
• Overview
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in RNA Sequencing Market: ESG Perspective
• ESG Practices in the RNA Sequencing Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 6 RNAi Technologies and Global Markets ( BIO127C)

• Scope of Report of RNAi Technologies
• Market Snapshot of RNAi Technologies
• Market Summary of RNAi Technologies
• Market Overview of RNAi Technologies
• RNA Interference Overview
• RNA Interference: Mechanism of Action
• Initiation Phase
• Effector Phase
• Small Interfering RNAs (siRNAs)
• MicroRNAs (miRNAs)
• Small Hairpin RNAs (shRNAs)
• Market Dynamics of RNAi Technologies
• Market Drivers
• Market Challenges
• Emerging Technologies and Opportunities of RNAi Technologies
• Therapeutics
• Diagnostics
• Circulating miRNA Diagnostics for Non-invasive Health Monitoring
• Agriculture
• Market for RNAi Technology by Technology
• Therapeutics
• Diagnostics
• Reagents and Tools
• Agriculture
• Market for RNAi Technology by Region
• Overview
• North America
• Europe
• Emerging Markets
• Sustainability in RNAi Technology Industry: An ESG Perspective
• Environmental Initiatives
• Social Initiatives
• Governance Initiatives
• Case Study
• Concluding Remarks from BCC

Chapter 7 Viral Vector and Plasmid DNA: Technologies and Global Markets (BIO192B)

• Scope of Report of Viral Vector and Plasmid DNA
• Market Outlook of Viral Vector and Plasmid DNA
• Market Summary of Viral Vector and Plasmid DNA
• Market Overview of Viral Vector and Plasmid DNA
• Cell and Gene Therapy
• Market Dynamics of Viral Vector and Plasmid DNA
• Market Driver
• Market Challenges
• Emerging Technologies and Opportunities of Viral Vector and Plasmid DNA
• AI in Viral Vector Production
• Doggybone DNA
• FRAGment Recycler: A New Technology for Plasmid DNA Synthesis
• Market for Viral Vector and Plasmid DNA Technologies by Product Type
• Market for Viral Vector and Plasmid DNA Technologies by Application
• Market for Viral Vector and Plasmid DNA Technologies by Region
• Overview
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest of the World
• Sustainability in the Market for Viral Vector and Plasmid DNA Technologies: An ESG Perspective
• Environmental Factors
• Social Factors
• Governance Factors
• ESG Performance Among Major Companies
• ESG Performance of Select Companies
• Lonza: ESG Performance
• Thermo Fisher: ESG Performance
• Conclusion

Chapter 8 Appendix

• Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Market for Gene Editing Therapeutics, Through 2029
• Table 2 : Comparison of Genome-Editing Tools
• Table 3 : U.S. Adults Age 50 Years and Older with Multiple Chronic Conditions, 2020-2050
• Table 4 : Global Cases and Deaths Due to Various Cancers, 2022
• Table 5 : Comparison of Cas9-derived Proteins with Regular SpCas9
• Table 6 : Global Market for Gene Editing Therapeutics, Through 2029
• Table 7 : Global Market for Gene Editing Therapeutics, by Region, Through 2029
• Table 8 : ESG Initiatives/Practices by Various Gene Editing Companies, 2023
• Table 9 : ESG Rankings for Companies in the Gene Editing Therapeutics Market, 2023
• Table 10 : Global DNA Sequencing Market, by Region, Through 2029
• Table 11 : DNA Transcription and Translation
• Table 12 : Types of Genetic Variation
• Table 13 : Molecular Diagnostic Technology Platforms
• Table 14 : Main Sequencing Applications
• Table 15 : Genetic Analysis Platform Comparison
• Table 16 : Key Applications in Microbial Sequencing
• Table 17 : Global DNA Sequencing Market, by Technology, Through 2029
• Table 18 : Different Generations of NGS Platforms
• Table 19 : Global DNA Sequencing Market, by Region, Through 2029
• Table 20 : Environmental Performance Initiatives in the DNA Sequencing Market
• Table 21 : Social Performance Initiatives in the DNA Sequencing Market
• Table 22 : Governance Performance Initiatives in the DNA Sequencing Market
• Table 23 : ESG Rankings for Key Players in DNA Sequencing Market, 2024*
• Table 24 : Global Market for Clinical Applications of Next-Generation Sequencing, by Disease Class, Through 2028
• Table 25 : Forces Influencing Growth in the Clinical NGS Market
• Table 26 : Key Trends in the Clinical NGS Testing Market
• Table 27 : Future Challenges in Implementing Clinical NGS
• Table 28 : Clinical NGS Research and Development Initiatives and Programs
• Table 29 : Global Market for Clinical NGS, by Disease Category, Through 2028
• Table 30 : Global Market for Clinical NGS, by Region, Through 2028
• Table 31 : Key Focus Areas in ESG Metrics
• Table 32 : ESG Rankings for Major Companies in the NGS Arena
• Table 33 : Illumina 2030 ESG Targets
• Table 34 : Global Market for RNA Sequencing, by Product, Through 2029
• Table 35 : Global Market for RNA Sequencing, by Technology, Through 2029
• Table 36 : Types of RNAs in Cells
• Table 37 : Comparison of Transcriptomics Methods
• Table 38 : Functional Elements in Sequencing Adapters
• Table 39 : Overview of Illumina's Sequencing Instruments
• Table 40 : Cloud Computing Providers for Genomics/RNA-Seq
• Table 41 : Global Market for RNA Sequencing, by Region, Through 2029
• Table 42 : Research Initiatives Focused on Personalized Medicine in Europe
• Table 43 : Key Focus Areas in ESG Metrics
• Table 44 : Environmental Performance Initiatives in the RNA Sequencing Market
• Table 45 : Social Performance Initiatives in the RNA Sequencing Market
• Table 46 : Governance Performance Initiatives in the RNA Sequencing Market
• Table 47 : ESG Rankings for Key Players in RNA Sequencing Market, 2024*
• Table 48 : Global Market for RNAi Technology, by Technology Type, Through 2029
• Table 49 : Cost Comparison of siRNA-approved Drugs and Alternative Therapies
• Table 50 : Global Market for RNAi Technology, by Technology Type, Through 2029
• Table 51 : RNAi Approved Drugs List
• Table 52 : miRNA-based Diagnostic Tools Available in Clinical Settings
• Table 53 : Global Market for RNAi Technology, by Region, Through 2029
• Table 54 : Key Focus Areas in ESG Metrices
• Table 55 : Environmental Initiatives, by Various RNAi Technology Companies
• Table 56 : ESG Rankings for Companies in the RNAi Technology Market, 2023
• Table 57 : Alnylam's ESG initiatives
• Table 58 : Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, Through 2028
• Table 59 : Global Incidence of All Cancers, by WHO Region, 2022-2050
• Table 60 : Global Market for Viral Vector and Plasmid DNA Technologies, Through 2028
• Table 61 : Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, Through 2028
• Table 62 : Global Market for Viral Vector and Plasmid DNA Technologies, by Application, Through 2028
• Table 63 : Global Market for Viral Vector and Plasmid DNA Technologies, by Region, Through 2028
• Table 64 : ESG Rankings of Major Companies, 2024*
• Table 65 : Lonza: ESG Performance
• Table 66 : Thermo Fisher: ESG Performance

List of Figures

• Figure 1 : Global Market for Gene Editing Therapeutics, 2021-2029
• Figure 2 : Emerging Technologies in the Genome-Editing Therapeutics Market
• Figure 3 : Global DNA Sequencing Market Shares, by Region, 2023
• Figure 4 : Global Market Shares of DNA Sequencing, by Technology, 2023
• Figure 5 : Global DNA Sequencing Market Shares, by Region, 2023
• Figure 6 : Global Market for Clinical Applications of Next-Generation Sequencing, by Disease Class, 2020-2028
• Figure 7 : Key Sustainable Practices Being Implemented in Research Laboratories
• Figure 8 : Global Market for RNA Sequencing, by Product, 2021-2029
• Figure 9 : Global Market for RNA Sequencing, by Technology, 2021-2029
• Figure 10 : RNA-Seq Experiments for Transcriptomics
• Figure 11 : RNA-Seq Experimental Workflow
• Figure 12 : Growth Strategy Recommendations: RNA Sequencing Market
• Figure 13 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
• Figure 14 : Global Market Shares of RNA Sequencing, by Product, 2024
• Figure 15 : Global Market Shares of RNA Sequencing, by Region, 2024
• Figure 16 : Growth Drivers in Asia-Pacific RNA Sequencing Market
• Figure 17 : Global Market for RNAi Technology, by Technology Type, 2021-2029
• Figure 18 : Global Market Shares of RNAi Technology, by Technology Type, 2023
• Figure 19 : Global Market for RNAi Technology, by Region, 2021-2029
• Figure 20 : Global Market Shares of RNAi Technology, by Region, 2023
• Figure 21 : Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, 2020-2028
• Figure 22 : Global Market Shares of Viral Vector and Plasmid DNA Technologies, by Product Type, 2022